Indian Journal of Economics and Development

Open Access Open Access  Restricted Access Subscription Access

TRIPS Agreement:The Indian Experience of Pharmaceuticals Industry and Agriculture


Affiliations
1 Department of Economic Sciences, Indian Institute of Technology, Kanpur, India
 

Background/Objectives: To analyze the Pharmaceuticals and Agricultural sector of India which, before implementation of WTO’S TRIPS agreement, was able to develop cheap outputs by “riding-on” research and technological advancements of other nations.

Methods/Statistical analysis: The methodology of this study is descriptive in nature and therefore no statistical approaches have been used in majority of the paper except for digression into the analysis of IP protection on FDI inflows in the BIMSTEC countries. For that analysis linear OLS regression model has been employed and the results have been computed using E-Views. The major part of this study has been the data collection which has been sourced from CMIE, RBI, WIPO and DGCIS databases.

Findings: From 1990 to 2008, there has been a gradual rise in imports and exports of pharmaceutical products in India. However the share of Drugs and chemicals in the total exports has decreased after 2005, post TRIPs transition. Moreover the regression analysis of FDI inflows with IP protection shows that the countries tend to invest more in the countries with stronger intellectual property protection.

Application/Improvements: The models provided in way forward can very well be employed in any of the emerging and least developed countries. The models discussed are very much relevant for sub-African and African countries where the access to medicines and food is a major concern


Keywords

TRIPS, WTO, Intellectual Property, Ginarte-Park, PIPP, Pharmaceuticals.
User
Notifications

  • R. Gabble, C.J. Kohler. Patent or not to patent? The case of Novartis’ cancer drug Glivec in India. Globalization and Health. 2014.

  • P. Moser. How Do Patent Laws Influence Innovation? Evidence from Nineteenth-Century World’s Fairs. The American Economic Review. 2005; 95(4), 1214-1236.

  • S. Kanwar, R. Evenson. Does intellectual property protection spur technological change? Oxford Economic Papers. 2003, 55 (2), pp.235-264.

  • B. Dhar, K.M. Gopakumar. Post-2005 TRIPS scenario in patent protection in the pharmaceutical sector: The case of the generic pharmaceutical industry in India. 2006; 1-79.

  • N. Kumar. Intellectual property rights, technology and economic development: experiences of Asian countries. Economic and Political Weekly. 2003; 38(3), 209-226.

  • Impact of TRIPS in India: An Access to Medicines Perspective. https://books.google.co.in/books?id=4ZMnAQAAMAAJ. Date accessed: 13/10/2010.

  • K. Chaturvedi, J. Chataway. Innovation in the post-TRIPs Regime in Indian pharmaceutical firms: implications for pharmaceutical RD model. 2006; 1-22.

  • K. Archana. Trips and the impact on plant variety protection in India. International Journal of Scientific & Engineering Research. 2013; 4 (5), 1-11.

  • W.G. Park, J.C. Ginarte. Intellectual property rights and economic growth. Contemporary Economic Policy. 1997; 15, 51-61.

  • M. Liu, S.L. Croix. A cross-country index of intellectual property rights in pharmaceutical inventions. Research Policy. 2015; 44(1), 206-216.


Abstract Views: 215

PDF Views: 117




  • TRIPS Agreement:The Indian Experience of Pharmaceuticals Industry and Agriculture

Abstract Views: 215  |  PDF Views: 117

Authors

Sachin Angural
Department of Economic Sciences, Indian Institute of Technology, Kanpur, India

Abstract


Background/Objectives: To analyze the Pharmaceuticals and Agricultural sector of India which, before implementation of WTO’S TRIPS agreement, was able to develop cheap outputs by “riding-on” research and technological advancements of other nations.

Methods/Statistical analysis: The methodology of this study is descriptive in nature and therefore no statistical approaches have been used in majority of the paper except for digression into the analysis of IP protection on FDI inflows in the BIMSTEC countries. For that analysis linear OLS regression model has been employed and the results have been computed using E-Views. The major part of this study has been the data collection which has been sourced from CMIE, RBI, WIPO and DGCIS databases.

Findings: From 1990 to 2008, there has been a gradual rise in imports and exports of pharmaceutical products in India. However the share of Drugs and chemicals in the total exports has decreased after 2005, post TRIPs transition. Moreover the regression analysis of FDI inflows with IP protection shows that the countries tend to invest more in the countries with stronger intellectual property protection.

Application/Improvements: The models provided in way forward can very well be employed in any of the emerging and least developed countries. The models discussed are very much relevant for sub-African and African countries where the access to medicines and food is a major concern


Keywords


TRIPS, WTO, Intellectual Property, Ginarte-Park, PIPP, Pharmaceuticals.

References